VITILIGO TREATMENTS - New Method

Vitiligo Treatments

The Vitiligo is a skin disorder, which destroys the melanocytes unknown to the skin, mucous membranes, eyes, hair and pears. The key 1% to 2% of the world and at least 1-2 million people in the U.S. alone. No sexual preference, and although all races are affected, is of particular importance in patients with darker skin. The highlight of the occurrence of the disease is 10 to 30 years old, and in half the cases, the disease manifests itself in the first two decades of life. The disorder begins Progressive, in white with Macul for an initial period of rapid growth followed by periods of latency. Repigmentation spontaneous seen from time to time. There is an element of the inheritance of the disease, since 30% of patients with vitiligo have a family. Stress, illness and personal crises have been associated with the occurrence of the disease. The Vitiligo is a deep psychological effect on patients, with two thirds of patients a deficit because of the possibility of the psychosocial effects of the disease.



Clinically, the patients with a circumscribed depigmented and hypopigmented Macul. Various Macul these millimeters to centimeters in diameter and are oval-to-tower shape. They have scalloped (concave) edges, which appear as if the affected areas are the invasion of the surrounding normal skin. Convexity of the severity of the injuries was repigmentation. The changes are usually Macul and triple-color model with a third or even fourth interim color, within the lesion. The face, back, wrists, armpits, navel and genitals are places of pain. Depigmented inflammation of the lesions with the borders can be seen at 2% to 5% of patients. The phenomenon is vitiligo injuries Koebner on the website traumatized. This applies to one third of patients, and Macul more or less like the original location of the lesion.

Vitiligo childhood is a subgroup of the disease in children under 12 years, in which it leads to increased incidence of vitiligo segmented. These children have an increased incidence of car-specific serum and in the wrong answers to topical PUVA therapeutic problems. In a study of 82 children with vitiligo, their families and had an increased incidence of car and diseases of the glands compared to the controls.

A variety of theories have been formulated to the cause of this disorder. The theory suggests that the neurons in the vicinity of nerve cells, an Ombudsman, the neurochemical is toxic to the melanocytes. The self, which says the theory is the synthesis of melanin is toxic to the melanocytes. Normally these melanocytes these metabolites can be dangerous, but the imbalances of the system can occur.

Pigmented eye abnormalities (hypopigmented hyperpigmentierten or choroidalen and retinal Pigmentepithels, uveitis) were in 40% of patients with vitiligo. ACUITY was the poor visibility at night, photophobia, and are about 5% of patients. In a study of 35 patients with a result of the control group, 43% (15) had one or more signs of a disease of the thyroid, compared to 20% (7) of controls. Vitiligo patients also have an increased incidence of thyroid cancer car.

The diagnosis is based on a good history and physical examination. It is important to define the development of the disease, to determine the aggressiveness of treatment. Inform yourself about the factors that exposure to chemicals, recreation and exposure to chemicals is very important because a large number of chemicals can Leukoderma.

The goal of treatment is to restore the pigmentation and thus improving the representation of the affected patients. The reserve requirements for the repigmentation melanocytes migrate to the normal skin and hair. Oral and topical psoralens photochemotherapy (PUVA), electrophoresis (trisoralen and the light of the sun), the topical corticosteroids.

Of these, the PUVA the highest efficiency, but a few months last May Debate three times per week, a significant improvement. Dermabrasion inclusion of new therapies and topical 5-fluorouracil, khellin and UVA light, and L-phenylalanine.

If you PUVA, is crucial to a test for the detection of anti-antibodies to disseminate lupus erythematosus, a disease in which light therapy is contraindicated. A screen chemistry is generally due to diseases of the liver and kidneys may on the metabolism of the oral psoralens. Autologous transplantation of skin may be useful to injuries isolated. The side effects of these new therapies are the scars, stains repigmentation, paving and the nature of the skin. In vitiligo with little residual normal pigmentation, which is reached, a more selective acceptable cosmetic effect. Vitiligo Treatments

copyright 2008 vitiligo treatments

Vitiligo Treatments

Vitiligo Treatments

What are the Vitiligo Treatments?
Vitiligo should be treated only if it causes emotional or social distress. It is much less noticeable in people with light complexion and is more obvious if you are tan. Use a sunscreen with a sun protection factor of at least 15 to prevent tanning May be part of your Vitiligo Treatments. The goal of treating vitiligo is to restore the function of the skin and improve the patient's appearance. Therapy for Vitiligo Treatments takes a long time - it must usually be continued for 6 to 18 months. The choice of
therapy depends on the number of white spots and the extent they are and on the preference of the patient for treatment. Every patient reacts differently to therapy, and special Vitiligo Treatments May not work for everyone. Current treatment options for Vitiligo Treatments, surgical and adjunct therapies (therapies that can be used in combination with surgery or medical Vitiligo Treatments).



Vitiligo Treatments with Steroide topical

Steroids May be useful in repigmenting the skin (back to the colour white spots), especially if started early in the disease. Corticosteroids are a group of drugs similar to hormones produced by the adrenal glands (cortisone). Doctors often prescribe a mild topical corticosteroid cream for children under 10 years and higher for adults. Patients should apply the cream to white spots on the skin for at least 3 months before seeing results. It is the simplest and safest treatment, but not as effective as psoralen photochemotherapy (see below). The doctor will closely monitor the patient side effects such as withdrawal stretch skin and skin (or lines streaks on the skin).


Vitiligo Treatments with Psoralene Photochemotherapy

Psoralene photochemotherapy (psoralen and ultraviolet A therapy, or PUVA) is probably the most beneficial for the treatment of vitiligo available in the USA. The objective of PUVA therapy is to repigment the white spots. However, it takes time and precautions must be taken to avoid side effects, which can sometimes be serious. Psoralènes are drugs that contain chemicals that react with ultraviolet light to cause darkening of the skin. The treatment involves taking psoralen by mouth (oral) or applied to the skin (topical). It is followed carefully by the time of exposure to ultraviolet A (UVA) light a lamp or sunlight. The patients receive their treatment in doctors' offices so that they can be observed carefully for side effects. Patients should minimize exposure to sunlight at other times.


Vitiligo Treatments with Psoralene topical photochemotherapy

Photochimiothérapie psoralen topical is often used for people with a few patches of depigmented (affecting less than 20 percent of the body). It is also used for children 2 years and older who have localized patches of vitiligo. The processing is done in a doctor's office under artificial light rays once or twice a week. The doctor or nurse applies a thin layer of psoralen patient depigmented patches about 30 minutes before exposure to UVA light. The patient is then exposed to a quantity of light rays that transforms the affected area pink. The doctor usually increases the dose of UVA light slowly over many weeks. Finally, the pink and areas fade a more normal skin color appears. After each treatment, the patient or his washing his skin with soap and water and apply sunscreen before leaving the doctor's office.

There are two main potential side effects of current PUVA therapy: (1) severe sunburn and blistering and (2) or too repigmentation darkening treatment patches or normal skin surrounding the vitiligo (hyperpigmentation). Patients can reduce their chances of sunburn if they avoid exposure to direct sunlight after each treatment. Hyperpigmentation is usually a temporary problem and eventually disappear when the treatment is stopped.


Vitiligo Treatments Psoralène oral photochemotherapy

PUVA oral therapy is used for people with larger vitiligo (affecting more than 20 percent of the body) or for people who do not meet current PUVA therapy. Psoralène oral is not recommended for children under 10 years due to an increased risk of damage to the eyes, like cataracts. Oral PUVA therapy, the patient takes a prescribed dose of psoralen by mouth about 2 hours before UVA exposure to artificial light or sunlight. The doctor adjusts the dose of light until the skin of the treated areas become pink. Salaries are usually two or three times a week, but never 2 days.

For patients who can not go to a facility PUVA, the doctor prescribe May psoralen to be used with natural sunlight exposure. The doctor will give the patient carefully the instructions on the completion of a home Vitiligo Treatments and monitor the patient during examinations.

Side effects known to include oral psoralen sunburn, nausea and vomiting, itching, abnormal hair growth, and hyperpigmentation. Psoralène oral photochemotherapy May increase the risk of skin cancer. To avoid sunburn and reduce the risk of skin cancer, patients with oral PUVA therapy should apply sunscreen and avoid direct sunlight for 24 to 48 hours after each treatment. Patients should also wear protective sunglasses UVA for 18 to 24 hours after each treatment to avoid eye damage, especially cataracts.


Depigmentation of Vitiligo Treatments

Dépigmentation implies the rest discoloration of the skin on the body match already white areas. For people who have vitiligo on more than 50 percent of their body, depigmentation May be the best Vitiligo Treatments option. Patients apply the drug monobenzylether of hydroquinone (monobenzone or Benoquin) twice daily for pigmented areas until they correspond to areas already depigmented. Patients should avoid direct skin to skin with other people for at least 2 hours after application of drugs.

The main side effects of therapy depigmentation is an inflammation (redness and swelling) of the skin. Patients May experience itchy, dry skin, or abnormal darkening of the membrane covering the white of the eye. Dépigmentation is final and can not be reversed. In addition, a person who suffers depigmentation will always be abnormally sensitive to sunlight.

source - http://vitiligotreatments.info Vitiligo Treatments